See every side of every news story
Published loading...Updated

Bernie Sanders backs effort to cut drug costs, urges stronger action

  • Today, President Donald Trump issued a directive instructing the Health and Human Services Department to reduce prices for certain Medicare-covered medications administered in doctor's offices.
  • The order mirrors a 2020 directive that was blocked by the courts and seeks to tie Medicare drug reimbursement rates to the prices charged for the same medications in a selection of other economically advanced nations, using a "most favored nation" pricing strategy.
  • The plan affects injectable and infusion drugs administered under Medicare Part B, requiring manufacturers to reduce prices within 30 days or face new government payment limits.
  • Pharmaceutical industry critics warn this strategy gives foreign governments the 'upper hand' and harms innovation, while Trump stated, 'We’re all going to pay the same' during a news conference.
  • If manufacturers do not negotiate lower prices, the health department will impose rules tying U.S. Drug prices to those in other countries, potentially generating substantial government savings.
Insights by Ground AI
Does this summary seem wrong?
Podcasts & Opinions

73 Articles

All
Left
14
Center
23
Right
5
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 55% of the sources are Center
55% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

drugstorenews.com broke the news in on Monday, May 12, 2025.
Sources are mostly out of (0)